• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Vanda Pharma Publishes Imsidolimab GPP Study in NEJM Evidence

    PR NEWSWIRE

    Oxford, Serum Institute Ink New Malaria Vaccine Pact

    ECONOMICTIMES

    Lighthouse Pharma Closes $12 Million Series A Financing

    PR NEWSWIRE

    Revolution Issues Legal Threat to Erasca as Rivalry Heats

    BIOSPACE

    Emergent, Substipharm Partner on JE Vaccine Manufacturing

    GLOBENEWSWIRE

    Boehringer, Zealand`s Obesity Drug Resembles Novo`s Wegovy

    BIOSPACE

    AbbVie Seeks FDA Approval for RINVOQ in Severe Alopecia Areata

    PRESS RELEASE

    Incyte Claims Double Phase 3 Wins in Vitiligo, Plans NDA Filing

    ENDPOINTS

    Profluent, Lilly Partner In $2.25B Genetic Medicine Deal

    REUTERS

    Biomolecular Holdings Issues Foundational Patents

    FIRSTWORD PHARMA

    Acrobiosystems Highlights Ai Innovation At AACR 2026

    PR NEWSWIRE

    CARB-X Funds Adjane For Gonorrhea Vaccine Development

    PR NEWSWIRE

    LayerBio Announces FDA Acceptance of IND for OcuRing-K

    ACCESSWIRE

    Genezen, Gray Foundation Partner on CLN6 Batten Therapy

    FIRSTWORD PHARMA

    mbiomics Announces Third Closing of Series A, Reaching €30M

    GLOBENEWSWIRE

    Rice Biotech`s Launch Pad Wins Award For Advancing Cell Therapy

    PR NEWSWIRE

    Coultreon Bio Secures $125M For Immunology Pipeline Advancement

    GLOBENEWSWIRE

    Hkeybio Cuts NHP Autoimmune Prices During Global Monkey Shortage

    PR NEWSWIRE

    BioNJ Joins NJ Innovation Hub With Portal As Foundational Member

    PR NEWSWIRE

    CTIBIOTECH Secures Funding to Advance Personalized Oncology

    PHARMIWEB

    Zealand Pharma Reveals Boehringer`s Dual Agonist Survodutide

    GLOBENEWSWIRE

    Transpire Bio Opens New R&D Site In Shanghai, China

    PR NEWSWIRE

    Trailhead Biosystems Expands Ipsc Cell Portfolio With Trailbio

    FIRSTWORD PHARMA

    Thermo Fisher Opens U.S. Bioprocess Design Center

    PHARMIWEB

    Theolytics Doses First Patient in Phase 1 Ovarian Cancer Trial

    GLOBENEWSWIRE

    Protagonist Exercises U.S. Opt-Out Right for Rusfertide

    PHARMIWEB

    FDA Accepts Zipalertinib NDA for EGFR Exon 20 NSCLC Cancer

    PHARMIWEB

    Silexion Therapeutics Submits SIL204 Phase 2/3 Trial Application

    GLOBENEWSWIRE

    Scancell Wins FDA Fast Track for iSCIB1+ in Advanced Melanoma

    GLOBENEWSWIRE

    Quoin Pharma Provides QRX009 Clinical and Regulatory Update

    GLOBENEWSWIRE

    PTC Therapeutics To Share PIVOT-HD Study Long-Term Results

    PR NEWSWIRE

    Proxigen Broadens Platform For Advanced Induced Proximity

    FIRSTWORD PHARMA

    Precision Biosciences Presents At ASGCT 2026 Annual Meeting

    PHARMIWEB

    Organogenesis Completes BLA Submission for ReNu

    GLOBENEWSWIRE

    Orca Bio Secures FDA RMAT Tag for Orca-Q in Blood Cancers

    PHARMIWEB

    Novo Nordisk at ECO: Wegovy & Next-Gen Weight Loss Treatments

    GLOBENEWSWIRE

    Neurogene To Present Therapeutic Rationale For ICV Delivery

    PHARMIWEB

    LIR Life Sciences Begins Study on Enhanced Transdermal Delivery

    PHARMIWEB

    Legend Biotech Hosts Investor Call On Q1 2026 Results

    GLOBENEWSWIRE

    Latus Bio To Present ASGCT 2026 Data Backing Gene Therapy

    PHARMIWEB

    Kestrel Therapeutics Launches Phase 1 KST-6051 Trial

    GLOBENEWSWIRE

    Jyong Biotech Advances Market Access for Botanical Drugs

    FIRSTWORD PHARMA

    Juniper Biosciences Collaborates On F-MISO Precision Diagnostic

    FIRSTWORD PHARMA

    IGC Pharma Engages Caregivers as CALMA Phase 2 Nears Completion

    PHARMIWEB

    iECURE to Present ECUR-506 Data in OTC Deficiency Trial

    FIRSTWORD PHARMA

    Gensight Biologics Sets Annual General Meeting For May 19, 2026

    FIRSTWORD PHARMA

    Genflow Biosciences PLC Expands Confidentiality Agreements

    PHARMIWEB

    Exciva Begins Dosing in Deraphan Trial for Alzheimer`s Agitation

    PHARMIWEB

    EvolveImmune Hits Preclinical Milestone with AbbVie

    GLOBENEWSWIRE

    Draig Therapeutics To Present At ASCP Annual Meeting

    FIRSTWORD PHARMA

    Creative Medical Posts 93% Response in Knee OA Program

    GLOBENEWSWIRE

    Concept Medical Reveals Positive 3-Year Results For Sirolimus

    INDPHARMAPOST

    Natural Field Unveils Nftrisolve Co-Loading Liposome Data

    PR NEWSWIRE

    Coave Therapeutics Introduces OneAAVTM Capsid At ASGCT 2026

    GLOBENEWSWIRE

    CellProthera, Quintessence Partner on Cell Therapy Manufacturing

    PHARMIWEB

    Cardiff Oncology Grants Inducement Under Nasdaq Rule 5635(c)(4)

    GLOBENEWSWIRE

    CAMP4 Therapeutics Preprints Study On Regulatory RNA Profiling

    GLOBENEWSWIRE

    Cabaletta Bio, Cellares Ink 10-Year Supply Deal For Rese-Cel

    GLOBENEWSWIRE

    China Approves First Recombinant Botulinum Toxin A Drug

    PR NEWSWIRE

    Bioxodes Unveils BIOX-101 ICH Breakthrough at ESOC 2026

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.